KELSEY J BRYANT
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NASHVILLE, TN NPI 1306376652
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TN UCB, Inc. All categories
General Payments — all program years on this page
$3,163.77
- Category: General Payments
- Program years: PY2022–2024
- Record count: 132
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,140.31 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,140.31 | 42 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $295.47 | 8 |
| SK Life Science, Inc. | $81.86 | 3 |
| Biogen, Inc. | $81.69 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $74.04 | 2 |
| EMD Serono, Inc. | $66.22 | 3 |
| CSL Behring | $64.98 | 2 |
| ARGENX US, INC. | $61.76 | 2 |
| PFIZER INC. | $47.67 | 2 |
| Lundbeck LLC | $46.31 | 2 |
| Teva Pharmaceuticals USA, Inc. | $40.21 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $36.52 | 2 |
| ABBVIE INC. | $32.55 | 1 |
| Neurelis, Inc. | $27.65 | 2 |
| Neurocrine BioSciences, Inc. | $26.81 | 1 |
| Axsome Therapeutics, Inc. | $26.72 | 1 |
| Alnylam Pharmaceuticals Inc. | $24.19 | 1 |
| Marinus Pharmaceuticals, Inc. | $23.90 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.75 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.64 | 1 |
| Celgene Corporation | $19.85 | 1 |
| Lilly USA, LLC | $19.52 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.